Our results demonstrated that OGT and the O-GlcNAcylation levels of UBAP2L, were significantly elevated in sunitinib-resistant ccRCC cells (Fig. 6E and S6G). Here, UBAP2L is linked to nonpapillary renal cell carcinoma.